Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |